retatrutide triple hormone receptor agonist Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more: https://go.lilly.com/msrz1v Today, we shared new data

Some antibiotics, particularly fluoroquinolones, can cause unpredictable glucose fluctuations that may require closer monitoring or temporary adjustment of diabetes medications

Sanofi is also dealing with the decline in insulin sales due to newer insulin products and biosimilars, which puts pressure on its pipeline

Some doctors argue that obesity is a chronic disease that should be treated with every effective tool available

Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions

Some research chemical suppliers and international compounding pharmacies offer retatrutide, though these sources operate outside normal pharmaceutical channels

Samtidig er mobiloptimering afgrende